Hemothorax: a rare presentation of COVID-19

On December 31, 2019 novel Coronavirus (SARS-CoV-2) is the strain of Coronavirus that causes Coronavirus disease 2019 (COVID-19) It was initially reported from Wuhan, China This novel virus causes atypical clinical presentations that differs from other viral pneumonias;in fact, some clinical aspects of infection are not cleared today We present the case of a 69-year-old man with a 2-week history of dyspnea and hemoptysis He was diagnosed with COVID-19 infection, confirmed by real-time reverse-transcriptase-polymerase chain reaction On day 11 postadmission, the case's condition improved significantly, with his oxygen saturation rising and lymphopenia subsiding His dyspnea gradually decreased in severity;furthermore, hemoptysis was controlled after treatment This case indicates the complexity and variety of pneumonia complications caused by COVID-19 infection We must have a high clinical suspicion in management of suspected cases especially in patients with novel clinical presentations such as our case in a pandemic Thus, hemothorax due to viral lung parenchymal destruction can be a complication of COVID-19 pneumonia